Rationale: Vascular smooth muscle cell (VSMC) migration and proliferation are the hallmarks of restenosis pathogenesis after angioplasty. Cyclooxygenase (COX)-derived prostaglandin (PG) E 2 is implicated in the vascular remodeling response to injury. However, its precise molecular role remains unknown. The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/
P ercutaneous transluminal coronary angioplasty is commonly used for the treatment of coronary heart disease. However, restenosis after angioplasty and stent deployment, considered as a wound healing response to mechanical injury, continues to be problematic in coronary interventional treatment, although application of drug-eluting stents has dramatically increased the success rate compared with that of bare metal stents. 1 Directional migration of vascular smooth muscle cells (VSMCs) from media to intima and their subsequent proliferation are the important processes for neointimal hyperplasia-lumen narrowing, followed by deposition of extracellular matrix, which together lead to self-remodeling of vessels (restenosis). 2 protein, and C3 complement, are associated with the increased risk of clinical angiographic restenosis. 4 Thus, investigators have proposed systemic anti-inflammatory approaches to prevent clinical restenosis. 5 Cyclooxygenase (COX) is a key enzyme for PG biosynthesis. Both isoforms, COX-1 and COX-2, are expressed in the vasculature 6 and can contribute substantially to the generation of vascular PG, including PGE 2 . 7 COX-2, an inducible isozyme and the dominant source of PGs in inflammation, is upregulated in vascular inflammation, such as atherosclerosis, 8 aortic aneurysm, 9 and balloon-injured arteries. 10, 11 Thus, elevated levels of PGE 2 , along with the induction of COX-2 in the vascular wall, is associated with the instability of plaque in the progression of atherosclerosis. 12 Pharmacological inhibition of COX-2, but not COX-1, reduces vascular neointimal hyperplasia in response to mechanical injury. 10, 11 Moreover, systematic inhibition of the production of PGE 2 caused by genetic disruption of microsomal prostaglandin E 2 synthase-1 (mPGES-1) attenuates neointima formation after vascular injury. 13 These findings strongly suggest that COX-2-derived PGE 2 might contribute to the pathogenesis of vascular restenosis.
A major source of the PGE 2 formed in vivo is derived from mPGES-1, and other PGES isozymes do not compensate when mPGE-1 is deleted. 7 Along with notably direct suppression of PGE 2 production, deletion of mPGES-1 reduces the neointimal hyperplasia response to vascular injury and results in cell-specific differential use of the accumulated PGH 2 substrates, such as predominant augmentation of prostacyclin (PGI 2 ) in VSMCs and thromboxane A2 in macrophages. 14 Genetic deficiency of the PGI 2 receptor (IP) enhances vascular proliferation response to wire injury; however, deletion of the thromboxane A2 receptor decreases this response. 15 Targeted deletion of mPGE-1 in VSMCs and macrophages differentially modulates the response to vascular injury in mice, 16 indicating direct impact of mPGES-1-derived PGE 2 on vascular remodeling, probably through its receptors known as EPs.
To test our hypothesis, we used COX-1>COX-2 mice, in which COX-1 is exchanged for COX-2 under the control of COX-2 regulatory elements, 17 and COX-2 knockout (KO) mice were used to address how COX-2-derived PGs are involved in the vascular remodeling in response to mechanical injury. We demonstrate here that PGE 2 , derived primarily from COX-2, accelerated vascular neointima formation in a vascular wire injury mouse model by comparing the vascular responses and PG profiles in 2 strains of mice. By screening different pharmacological inhibitors, the EP3 receptor was identified to mediate the VSMC migration response to PGE 2 stimulation. Disruption of EP3, particularly its α and β splice variants, impaired the polarity of VSMCs required for directional migration through inhibition of the activity of small GTPase activity, including RhoA, Rac1, and Cdc42. The activity of RhoA in VSMCs could be modulated by both EP3α and EP3β through the cAMP-dependent protein kinase A (PKA) pathway. Blockade of EP3 suppressed phosphatidylinositol 3-kinase (PI3K) signaling, reduced Rac1, RhoA, and Cdc42 activity in VSMCs, altered cell polarity, and restrained directional migration.
Methods
The detailed Methods section is available in the online-only Data Supplement.
Results

Deletion of COX-2 Conveys Protection Against Vascular Neointima Formation in Response to Injury
COX-1 and COX-2 were abundantly expressed in cultured VSMCs. Both mRNA and protein for COX-2, but not COX-1, were significantly upregulated by stimulation with lipopolysaccharide (LPS; Figure 1A and 1B). Similarly, the level of expression of the mRNA of the dominant PGE 2 synthase, mPGES-1, also increased significantly in response to LPS ( Figure 1B ). In the wire-injured artery model, COX-2 was strongly stained in the infiltrating inflammatory cells (CD68 + and CD11b + ) and in the proliferating VSMCs (α-actin-positive) in the neointima at different stages ( Figure 1C and Online Figure I), indicating that COX-2 activity contributes to the vascular response to the injury.
To test our hypothesis, we performed wire injury in the femoral arteries of wild-type (WT), COX-2 KO, and COX-1>COX-2 mice and evaluated neointima formation at day 28 after injury. COX-2 deficiency, as anticipated, led to significant reduction of the intima-to-media ratio (COX-2 KO 0.95±0.17 vs WT 1.70±0.25; P=0.02) and the percentage of luminal narrowing (restenosis index: COX-2 KO 25.59±3.38% vs WT 46.00±5.62%; P=0.005) compared with WT with abundant neointima formation ( Figure 1D and 1E). In contrast, the replacement of COX-1 in COX-1>COX-2 mice augmented the intima-to-media ratio (COX-1>COX-2 2.53±0.25 vs WT 1.70±0.25; P=0.03) and the restenosis index (COX-1>COX-2 64.5±6.4% vs WT 46.0±5.6%; P=0.04).
Immunohistochemical analysis revealed the presence of extensive inflammatory cell infiltration around the vasculature, as well as VSMC migration and proliferation in the intima in response to vascular injury (Online Figure IA , IC, and IE). COX-2 deletion coordinately suppressed the inflammatory response as compared with WT controls, but no overt differences were found between COX-1>COX-2 and WT mice (Online Figure IB and ID). 
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COX-2-Derived PGE 2 Is Involved in the Development of Injury-Induced Neointima Formation
Given the differing impact of COX-2 deficiency and the replacement of COX-2 activity by COX-1 on vascular remodeling ( Figure 1 ), we looked further into systemic PG metabolism and vascular PG generation of these strains. Vascular insult increased the excretion of all PG metabolites ( Figure 2 ) consistent with induction of COX-2 in the vasculature of WT mice ( Figure 1 ). Deletion of COX-2 led to the suppression of the levels of PGE 2 metabolite and PGI 2 metabolite in mice, because COX-2 is the dominant source of PGI 2 , 6 and COX-1 and COX-2 contribute to the production of PGE 2 . 7 However, the COX-1 insertion in COX-1>COX-2 mice rescued the decline in the levels of PGE 2 metabolite in COX-2 KO mice (10.3±2.31 ng/mg creatinine in COX-2 KO vs 24.1±3.9 ng/ mg creatinine in WT [P<0.05] vs 20.9±3.7 ng/mg creatinine in COX-1>COX-2 [P<0.05]; Figure 2B ) without significant influence on the suppression of urinary PGI 2 metabolite by deletion of COX-2 ( Figure 2C ). Similar PG measurements were observed after vascular injury, albeit with higher levels detected ( . Deletion of COX-2 had no impact on the excretion of urine PGD 2 metabolite and thromboxane A2 metabolite before and after injury. In cultured VSMCs, PGE 2 and PGI 2 were the dominant products of COX-2, and substitution of COX-1 for COX-2 can notably rescue PGE 2 , but not PGI 2 , production (measured as its stable hydrolysis product), which was decreased by COX-2 deletion (Online Figure II) . Thus, insertion of COX-1 in the COX-2 locus restored COX-2-derived biosynthesis of PGE 2 , not PGI 2 , in mice. Depletion of PGI 2 receptor (IP) in mice aggravated the vascular responses to injury, 15 as in COX-1>COX-2 mice with diminished PGI 2 ( Figure 2 ). Taken together, we surmise that the decrease of PGE 2 in COX-2 KO mice provides protection against injury-induced vascular remodeling. This occurs despite reduced production of vasoprotective PGI 2 , in which case COX-2 inhibition increases the risk of cardiovascular events in clinic. 8
The EP3 Receptor Mediates Migration of VSMCs on PGE 2 Stimulation
In response to de-endothelialization induced by mechanical injury, VSMCs migrate directionally from arterial media into the intima and begin proliferating, resulting in neointima formation and restenosis. 2 We first monitored the migration of VSMCs from COX-2 KO mice by a traditional scratch wound healing assay. COX-2 deficiency significantly inhibited wound closure at all time points tested (Online Figure III) . In particular, during the first 12 hours, cell proliferation is minimal, and wound closure at this time primarily reflects cell spreading and migration. 18 Because COX-2-derived PGE 2 is responsible for this process, and all 4 receptors for PGE 2 (EP1, EP2, EP3, and EP4) are expressed abundantly in cultured VSMCs and arteries and are not significantly altered in response to LPS stimulation ( Figure 3A ). Using specific antagonists, we determined the identity of the receptor(s) involved in mediating the VSMC migration. The migration of VSMCs challenged with PGE 2 was markedly reduced dosedependently by pretreatment with the EP3 receptor antagonist L-789,106 ( Figure 3B and 3C), whereas no significant effects were detected using EP1, EP2, and EP4 receptor antagonists ( Figure 3B ). To rule out the impact of cell proliferation, we performed transwell migration assays of VSMCs within 3 hours of treatment. Similarly, only the EP3 receptor antagonist L-789,106 strikingly attenuated VSMC migration (59% suppression compared with the vehicle control [ Figure 3D ], which again exhibited dose-dependent inhibition; Figure 3E ). Therefore, PGE 2 derived primarily from COX-2 promoted VSMC migration through the EP3 receptor.
Both EP3α and β Splice Variants Are Involved in Regulation of VSMC Migration and Injury-Induced Neointimal Hyperplasia
Using EP3 small interfering RNA directed at a site within exon 2 to disrupt all 3 mouse EP3 splice variants, EP3 expression was reduced by 80% in primary VSMCs, resulting in a 48% decrease in VSMC migration through the transwell assay (Online Figure IVA) . Likewise, EP3 deletion caused similar impairment of VSMC migration as the EP3 inhibitor ( Figure 4A ). Real-time polymerase chain reaction data showed that all PG receptors were expressed in VSMCs, and that EP3 disruption did not significantly alter the expression of other PG receptors, with or without LPS treatment (Online Figure V ). The 3 EP3 splice variants are expressed in VSMCs (Online Figure IVB) . To identify the EP3 variant that mediates VSMC migration induced by PGE 2 , VSMCs from WT mice were subjected to transfection with small interfering RNA specific for each variant. Real-time polymerase chain reaction demonstrated >70% reduction in the mRNA levels at 24 hours after transfection of the respective variants without significant compensation. Knockdown of EP3α and EP3β significantly impaired the capability of VSMC migration (EP3α inhibition 78.00±2.1 and EP3β inhibition 73.03±2.4 vs scrambled control 100.0±1.7; P<0.05; Online Figure IVC ). However, silencing of EP3γ did not significantly influence VSMC migration. We sought to determine whether re-expression/overexpression of EP3 variants could restore the ability of VSMC migration. Primary VSMCs isolated from EP3 KO mice were transfected with mouse EP3α, EP3β, or EP3γ cDNAs that were tagged with the hemagglutinin epitope at the N terminus. Robust induction of the expression of each EP3 variant was observed at 24 hours after transfection (Online Figure  IVD ). Overexpression of EP3α or EP3β rescued the ability of VSMCs to migration, which was inhibited previously by EP3 deficiency ( Figure 4B ), and this renewed capability correlates positively with expression of EP3α or EP3β ( Figure 4C ), whereas EP3γ overexpression showed very little influence on migratory behavior ( Figure 4B ). These data demonstrate that PGE 2 -induced VSMC migration is mainly mediated by EP3α and EP3β. Consistent with these results, in this vascular injury model, EP3 abolition rendered a decrease in the intima-to-media ratio (0.65±0.16 vs 1.34±0.15; P=0.005) and restenosis in EP3 KO mice (index, 23.4±5.0% vs 42.2±3.4%; P=0.007) compared with control mice ( Figure 4D ). The levels of PG metabolites were not significantly influenced by EP3 disruption in mice, even when subjected to wire injury (Online Figure VI) .
To further confirm the involvement of EP3α and EP3β in vascular remodeling, we delivered lentiviral vectors, each constitutively expressing EP3α, EP3β, or EP3γ, to the femoral arteries after wire injury ( Figure 4E ). After 4 weeks, expression of the EP3α and EP3β transgenes significantly reversed the inhibition of neointimal hyperplasia in EP3-deficient mice (intima-to-media ratio: EP3α overexpression 1.68±0.16 and EP3β overexpression 1.42±0.08 vs green fluorescent protein control 0.70±0.07; P<0.05), whereas vascular overexpression of EP3γ failed to significantly alter the vascular response to injury ( Figure 4E and 4F). Thus, these data indicate the EP3α and EP3β receptors play important roles in the vascular remodeling in response to injury.
Activation of EP3 Is Required for Polarity of Migrating VSMCs
The positioning of the microtubule organizing center (MTOC) relative to the nucleus toward the leading edge is a hallmark of migrating cell polarity. 19 Confluent cultures of VSMCs were wounded with a pipette tip and immunostained for the MTOC marker γ-tubulin and counterstained with 4',6-diamidino-2-phenylindole to visualize cell nuclei at the wound edge ( Figure 5A ).The MTOCs that localized between the nucleus and the leading edge were determined as front-polarized ( Figure 5B ). 20 Before wounding, the MTOC was randomly distributed with 20.1±1.0% of frontpolarized cells. Six hours after wounding, the percentage of front-polarized VSMCs increased to 40.4±8.5% (Online Figure VII) . Impairment of directional cell migration is accompanied by a loss of cell polarity toward the direction of migration. 20 Antagonism of the EP3 receptor activity by L-798,106 (10 μmol/L) markedly disrupted polarization of VSMCs and randomized the orientation of the MTOC front-polarized cells of EP3 antagonist vs control (13.5±3.4 vs 40.3±8.5; P<0.05; Figure 5B ). Comparable results were observed in VSMCs from EP3 KO mice with ≈16% frontpolarized cells (EP3 KO vs WT, 15.5±5.1 versus 42.3±12.1; P<0.05; Figure 5A and 5C).
Immunostaining for α-tubulin showed wound-facilitated formation of long and unbranched protrusions, which were oriented toward the direction of migration in intact VSMCs, whereas EP3 inhibition (L-798,106 or Gi protein blocker, pertussis toxin), or deletion of EP3, led to the formation of randomly oriented protrusions ( Figure 5D ). In migrating cells, protrusion of the leading edge requires the precise regulation of the lamellipodia and F-actin networks. 21 As indicated by F-actin staining, pharmacological inhibition of EP3 by L-798,106 or pertussis toxin sharply reduced the number of leading protrusions during VSMC migration (L-798,106 treatment, 1.29±0.20; pertussis toxin treatment 1.0±0.19 vs control 3.47±0.38; P<0.05; Figure 5E ). Similar suppression of leading protrusions was replicated in VSMCs derived from EP3 KO mice compared with WT (1.11±0.21 vs 3.40±0.36; P<0.05; Figure 5E ). These results suggest the migratory defect of VSMCs from EP3 KO is attributed to abnormal cell polarity.
Activity of Small GTPases Is Impaired in VSMCs From EP3 KO Mice
Rho GTPases are pivotal regulators for cell polarization 22 and directional migration. 23 Therefore, we performed standard pull-down assays using lysates prepared from primary VSMCs obtained from EP3 KO and WT mice and examined GTP-bound RhoA, Rac1, and Cdc42 in response to PGE 2 stimulation. RhoA activity was undetectable in untreated cultured VSMCs (data not shown) but was boosted robustly in the presence of PGE 2 , whereas EP3 disruption attenuated the induction of GTP-RhoA to 68% ( Figure 6A ). Overexpression of either EP3α or EP3β by transfection of EP3-deficient VSMCs resulted in upregulated RhoA activity on stimulation ( Figure 6A ). Again, Cdc42 and Rac1 activities that were low in VSMCs could be induced notably by PGE 2 . Deletion of EP3 resulted in a slight, but significant, increase in their activities, whereas re-expression of either EP3α or EP3β completely restored the suppression in EP3 KO VSMCs ( Figure 6B ). These observations indicate that either EP3α or EP3β was involved in regulating of RhoA, Cdc42, and Rac1 activation. 
EP3α/β Variants Are Coupled Via Gαi Protein to Regulated RhoA Activity and VSMC Migration Through a PKA Signaling Pathway
Evidence indicates EP3α and EP3β are coupled to Gαi. 24 To determine whether these G-protein interactions occur in VSMCs, hemagglutinin-tagged EP3α or EP3β was introduced into cultured VSMCs. Coimmunoprecipitation experiments displayed clear binding of EP3α or EP3β with Gαi using a hemagglutinin-tag antibody ( Figure 7A ), suggesting that either EP3α or EP3β suppresses adenylate cyclase activity and cellular cAMP levels. As anticipated, the levels of cAMP were significantly decreased by overexpression of either EP3α or EP3β receptors on stimulation with a PGE 2 analog misoprostol ( Figure 7B ). Accordingly, PKA activity was increased by 20% when EP3 was deleted in VSMCs and reduced by 40% and 36% by overexpression of EP3α or EP3β, respectively ( Figure 7C ).
Various lines of evidence suggest that PKA modulates activity of GTPases and influences cytoskeletal dynamics and cell migration. 25 To determine whether PKA is involved in the EP3-mediated RhoA activation, VSMCs were pretreated with a PKA inhibitor (H-89) before PGE 2 stimulation. As shown in Figure 7D , overexpression of EP3α or EP3β markedly elevated RhoA activity. Blocking PKA activity by H-89 also enhanced RhoA activation, which was more apparent in EP3 KO cells. Surprisingly, we failed to detect a consistent impact of PKA on Cdc42 and Rac1 by using H-89, even in cells overexpressing EP3 (Online Figure VIII) . Along with the increasing repositioning of MTOCs toward a scratch in the wound healing assay (EP3 KO 15.5±5.1% vs H-89/EP3 KO 32.6±5.9%; P<0.05; Figure 7E ), antagonism of the induction of PKA activity by EP3 deletion partially rescued the ability of VSMCs to migration in the transwell assay (EP3 KO 52.1±1.7% vs H-89/EP3 KO 62.1±1.1%; P<0.05; Figure 7F ), implying that additional EP3-mediated pathways may be involved. The inhibition of Rho signaling by the Rho-associated protein kinase (ROCK) inhibitor Y-27632 significantly delayed the migration of VSMCs, because ROCK1 and ROCK2 are the first effectors of Rho and participate in the formation of stress fibers and focal adhesions. 26 
The EP3α/β-Mediated PI3K-Akt-GSK3β Signaling Axis Modulates Migration and Polarization of VSMCs
Phosphorylation of glycogen synthase kinase (GSK)3β is implicated in the control of direction of cell protrusion by regulating the centrosome polarization. 27 To explore whether PGE 2 activates the PI3K/Akt/GSK3β signaling pathway through the EP3 receptor, we first determined inhibitory phosphorylation of GSK3β at Ser9. We found that in response to PGE 2 treatment, GSK3β underwent a rapid phosphorylation within 30 minutes, reaching a peak at 6 hours and fully recovered at 12 hours (Online Figure IXA and IXB) . The EP3 antagonist L-798,106 and Gαi blocker pertussis toxin suppressed PGE 2 -induced phosphorylation of GSK3β and Akt/PI3K signaling components (Online Figure IXB) . The phosphorylation of GSK3β and Akt also were attenuated in EP3 KO mice in either the absence or the presence of LPS, which activates the PI3K via Toll-like receptor 4 ( Figure 8A) . These results indicate that EP3 mediates the PI3K/Akt/GSK3β signaling by liberating Gβγ subunits on PGE 2 stimulation as previously described for other PGE 2 receptors. 28 Figure 5 . Pharmacological inhibition or genetic deletion of EP3 impairs the polarization of vascular smooth muscle cells (VSMCs) for directional migration. A, Representative confocal micrographs of primary postconfluent VSMCs isolated from wild type (WT) and EP3 knockout (KO) mice immunostained for γ-tubulin to localize the microtubule organizing centers (MTOCs, arrow) at 6 hours after wounding in the presence or absence of the EP3 antagonist, L-798,106. Nuclei were stained with 4',6-diamidino-2-phenylindole. The dashed box outlines the region enlarged to the right. Scale bar, 50 μm. B, Schematic of the method used for quantifying the position of the MTOCs of wound-edge cells. C, Quantitation of front-polarized VSMCs from WT and EP3 KO mice, with or without L-798,106 treatment 6 hours after wounding. *P<0.05 vs control for L-798,106 treatment or WT for EP3 KO, n=3. Scale bar, 50 μm. The results were repeated 3 times. D, Representative confocal micrographs of α-tubulin immunostaining of VSMCs from WT and EP3 KO mice, with or without L-798,106 treatment 6 hours after wounding. Scale bar, 50 μm. E, Representative confocal micrographs of F-actin (left) immunostaining of VSMCs from WT and EP3 KO mice, with or without L-798,106 treatment 6 hours after wounding. The white boxes outline the region enlarged (bottom). The number of cellular leading protrusions was quantitated as the number of leading protrusions divided by the number of cells at the leading edge (right). *P<0.05 vs control for L-798,106 treatment or WT for EP3 KO, n=3. Scale bar, 50 μm. The results were repeated 3 times.
We next asked whether EP3α/β mediated the PI3K/Akt/ GSK3β signaling, because these splice variants were involved in cell migration and polarization. Re-expression of either EP3α or EP3β in VSMCs from EP3 KO mice elevated the level of phosphorylation of Akt and GSK3β induced by PGE 2 . This effect was blunted by the PI3K selective inhibitor Wortmannin ( Figure 8B) . Moveover, re-expression of either EP3α or EP3β restored the phosphorylation of GSK3β in VSMCs isolated from EP3 KO mice, which was terminated by an Akt inhibitor 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (HIMO) or a GSKβ inhibitor SB216763 (Online Figure IXC) . These findings indicate that the EP3α and EP3β receptors mediate the activation of PI3K/Akt/GSK3β signaling. GSK3β may be phosphorylated by PKA in neurons. 29 However, H-89 treatment did not significantly influence GSK3β phosphorylation even in VSMCs overexpressing EP3α/β with enhanced phosphorylation (Online Figure IXD) , indicating that GSK3β phosphorylation occurs independently of PKA in VSMCs.
We next examined the effect of the EP3α/β-mediated activation of the PI3K/Akt/GSK3β pathway on MTOC reorientation and on cell migration. Enforced ectopic overexpression of either EP3α or EP3β in EP3-deficient VSMCs restored cell polarity within 6 hours by 3-fold or 2.8-fold, respectively, and augmented subsequent migration of VSMCs by 2-fold or 1.9-fold ( Figure 8E ), respectively. However, restorations of cell polarity and migration responses were abolished by pretreatment with Wortmannin, HIMO, or SB216763, which specifically inhibit signaling through the PI3K pathway ( Figure 8E) . Thus, the PI3K/Akt/GSK3β signaling axis is involved in the regulation of VSMC migration and polarity through the EP3α/β receptors.
The activation of Cdc42 and Rac1, key regulators of cell migration, 30 was impaired in EP3-deficient VSMCs. Again, re-expressing of either EP3α or EP3β in EP3-deficient VSMCs markedly rescued the decreased activation of Rac1 and Cdc42 (Figure 8C and 8D) . Pharmacological inhibition of PI3K (Wortmannin), Akt (HIMO), and GSK3β (SB216763) abrogated the activation of Rac1 induced by PGE 2 in EP3αexpressing, EP3β-expressing, and WT VSMCs ( Figure 8B) . Similarly, elevation of RhoA activity by transfection of VSMCs with either EP3α or EP3β was blocked by wortmannin, HIMO, and SB216763 (Online Figure X) . These results suggest that Rac1 and RhoA activity can be regulated by the EP3α/βmediated PI3K/Akt/GSK3β signaling pathway ( Figure 8F ). However, elevation of Cdc42 activity by EP3α or EP3β transfection with either EP3α or EP3β cDNA was blunted by the selective PI3K inhibitors, wortmannin, and LY294002 but not affected significantly by HIMO or SB216763 ( Figure 8B) , indicating that the PGE 2 -induced Cdc42 activation depends on PI3K activity through the EP3α/β receptors ( Figure 8F ).
Discussion
Vascular remodeling is differentially regulated by PGs derived from COX-1 and COX-2. Pharmacological inhibition of COX-2 suppresses the vascular remodeling in response to balloon injury, 10, 11 whereas genetic knockdown (data not shown) or pharmacological inhibition of COX-1 does not effect this response. We found here that deletion of COX-2 or the downstream EP3 receptor attenuates vascular neointima formation after wire injury in mice; VSMC migration and cell polarization toward directional migration stimulated by PGE 2 could be impaired by pharmacological inhibition or genetic modulation of EP3α or EP3β receptors through downregulation of small GTPases. Activation of the EP3α or EP3β receptors directly fine-tune RhoA activity through inhibitory Gαi signaling, whereas liberated Gβγ subunits regulate Cdc42, Rac1, and RhoA activities in VSMCs through the PI3K/Akt/ GSK3β pathway.
COX-2 expressed in vasculature, including VSMCs, 6 is markedly induced during vascular inflammation. [9] [10] [11] 31 Vascular COX-2 is the dominant source of PGI 2 and PGE 2 . 5 Thus, deletion of COX-2 significantly reduces systemic PGE 2 and PGI 2 production. 7, 32 As shown by the data presented in Figure 2 and Online Figure I, COX-1 knocked-in to the COX-2 locus (COX-1>COX-2) could rescue PGE 2 production, but not PGI 2 , production, 33 which aggravated the vascular response to injury, consistent with previous observations on the disruption of the IP receptor. 15 Analogous to pharmacological studies, COX-2 deficiency conferred protection against neointima formation along with decreased production of PGE 2 and PGI 2 . Therefore, we reasoned that COX-2-derived PGE 2 , from both VSMCs and the infiltrated inflammatory cells, predominantly promoted vascular neointimal hyperplasia, because impaired PGE 2 synthesis in mice attenuates the vascular response. 13 In this study, COX-2 deletion impaired VSMC migration, whereas exogenous PGE 2 accelerated VSMC migration. Pharmacological inhibition, gene silencing using small interfering RNA, or genetic deletion of the EP3 receptor restricted PGE 2 -induced VSMC migration, indicating that COX-2-derived PGE 2 mediated VSMC migration through EP3 α/β activation ( Figure 2) . Recently, EP3 was to shown to promote the migration of other cells, such as airway smooth muscle cells. 34 Deficiency of EP3 attenuated the thickening of the neointima, whereas overexpression of EP3α or EP3β in vasculature augmented its formation in mice, which suggests that EP3-mediated VSMC migration contributes to the vascular remodeling in response to mechanical injury. Because endothelium loss triggers VSMC migration through fenestrae in the internal elastic lamellae into the intima and subsequent proliferation, 35 EP3 may be involved in mediating the early events in restenosis, although other PGE 2 receptor subtypes, such as EP2, 36 or perhaps EP4, 37 might participate in later events, including VSMC proliferation. However, different EP receptors play different roles in stabilizing atherosclerotic plaque. 38 Small GTPases, including Rho, Rac, and Cdc42, are pivotal for MTOC orientation and for cell migration. 39 Pharmacological inhibition or genetic deficiency of EP3 impaires MTOC reorientation and decreases the activities of Rac1, RhoA, and Cdc42 on PGE 2 stimulation, which lead to restriction of VSMC migration and reduction of vascular neointima formation in response to injury in mice. These observations also are consistent with the notion that repositioning the centrosome stabilizes the chosen direction of movement through regulation of the microtubule system. 40 Cdc42 is believed to be a master regulator of cell polarity by directing MTOCs reorientation toward the direction of movement, 41, 42 despite accumulated evidence showing that Rho and Rac are involved in the coordinate regulation of cell polarization. [43] [44] [45] In the present study, pharmacological inhibition of PI3K signaling diminished Cdc42 activity and disrupted the reorientation of the MTOCs in cells overexpressing EP3α/β receptors. Surprisingly, inhibition of Akt and GSK3β, which act downstream of PI3K, reduced Rac1 and RhoA activity in VSMCs without a detectable impact on Cdc42 and inhibited the reorientation of the MTOCs toward directional migration, suggesting the involvement of Rac1 and RhoA in the microtubule rearrangement and cell polarity as described previously. 46 EP3α and EP3β splice variants couple with Gαi, resulting in the inhibition of adenylyl cyclase, whereas activation of the EP3γ elevates cAMP, probably through Gαs. 24 Stimulation of G-protein-coupled receptors activate PI3K/Akt/GSK3β signaling by free Gβγ or indirectly by Gα by competitive binding of axin and releasing the GSK3β substrate-β-catenin. 28 Here, we found that the EP3α or EP3β receptors, but not EP3γ, mediated VSMC migration and vascular neointimal hyperplasia in mice. The Gαi-mediated PKA pathway, signaling through the PI3K/Akt/GSK3β pathway that mediated cell migration, was shown to occur on activation of EP3α or EP3β receptors through the liberation of their coupled Gβγ subunits in VSMCs. PKA inhibits RhoA-dependent function by inducing Ser188 phosphorylation of RhoA and subsequent cytoplasmic sequestration of GTP-RhoA by Rho GDP dissociation inhibitor. 47 Coincidentally, EP3 inhibition or deletion reduced, whereas overexpression of EP3α or EP3β elevated, RhoA activity through a Gαi-mediated cAMP/PKA pathway. RhoA and its key downstream effector ROCK are involved in neointima formation after vascular injury, 48 probably through regulation of cell shape and migration by modulating stress fiber formation. 49 We also observed a partial but significant increase of VSMC migration through upregulation of RhoA activity by inhibition of PKA, despite substantial suppression effect of ROCK inhibitor. Moreover, we failed to detect analogous inhibitory effects of H-89 on the activity of Rac1 and Cdc42 in VSMCs similar to that of RhoA (Online Figure IX) . These observations strongly indicate additional non-cAMP/PKA pathways mediated by EP3α/β receptors are involved in the regulation of VSMC migration and activity of small GTPases.
The phosphorylation status of GSK3β, a key downstream substrate of PI3K and Akt, is essential for maintaining cell polarity. 27 PGE 2 stimulation and wound scratch activated PI3K signaling and induced rapid inhibitory phosphorylation of GSK3β in VSMCs, which could be attenuated by genetic deficiency or pharmacological inhibition of EP3. Moreover, the reduced PI3K signaling in EP3 KO VSMCs could be rescued by the EP3α/β overexpression. Pharmacological inhibition of the EP3α/β-activated PI3K signaling reduced the capability of migration and impaired the repositioning of the MTOCs. These observations demonstrate that PI3K/Akt/GSK3β signaling mediated by the EP3α/β receptors is involved in the regulation of migration and polarization of VSMCs and the vascular remodeling response to injury.
In summary, we showed that COX-2-derived PGE 2 accelerates neointima formation in response to injury through the EP3α/β receptors in mice, and that the EP3α/β-mediated Gαi/cAMP/PKA and Gβγ/PI3K/Akt/GSK3β pathways play a role in regulation of the activation of small GTPases and the subsequent VSMC polarization and migration on stimulation with PGE 2 . Given that selective inhibition of COX-2 confers a cardiovascular hazard attributable to inhibition of COX-2derived PGI 2 , inhibition of signaling through the EP3 receptor may be a viable target for prevention of in-stent restenosis. 
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